Prevalence and consequences of nonadherence to hemodialysis regimens

American Journal of Critical Care

Volumn 16, Issue 3, 2007, Pages 222-236

  Denhaerynck, Kris ^a   Manhaeve, Dominique ^b   Dobbels, Fabienne ^c   Garzoni, Daniela ^d   Nolte, Christa ^d   De Geest, Sabina ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b TIBOTEC BVBA   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; DIET; HOSPITAL MANAGEMENT; HUMAN; PATIENT COMPLIANCE; PREVALENCE; RENAL REPLACEMENT THERAPY; REVIEW; TREATMENT REFUSAL;

APPOINTMENTS AND SCHEDULES; CLINICAL PROTOCOLS; DIET; HUMANS; PATIENT COMPLIANCE; PREVALENCE; RENAL DIALYSIS; TREATMENT REFUSAL;

EID: 34250818890     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. European Renal Association-European Dialysis and Transplant Association. ERA-EDTA Registry 2004 Annual Report. Amsterdam, the Netherlands: Department of Medical Informatics, Academic Medical Center; 2006.
2. US Renal Data System. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases; 2006.
3. Locatelli F, Marcelli D, Conte F, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol. 2001;12:2411-2417.
4. Chan CT. Cardiovascular effects of frequent intensive hemodialysis. Semin Dial. 2004;17:99-103.
5. Horl MP, Horl WH. Hypertension and dialysis. Kidney Blood Press Res. 2003;26:76-81.
6. Dunbar-Jacob J, Foley S. A historical overview of medication adherence. In: Dunbar-Jacob J, Erlen J, Schlenk E, Stilley C, eds. Methodological Issues in the Study of Adherence. Pittsburgh, Pa: School of Nursing, University of Pittsburgh; 2005.
7. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005;20:1048-1056.
8. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2003;42(6 suppl 5):A5-A7.
9. Sabaté E, ed. Adherence to Long-term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
10. Wolcott DL, Maida CA, Diamond R, Nissenson AR. Treatment compliance in end-stage renal disease patients on dialysis. Am J Nephrol. 1986;6:329-338.
11. Schneider MS, Friend R, Whitaker P, Wadhwa NK. Fluid non-compliance and symptomatology in end-stage renal disease: cognitive and emotional variables. Health Psychol. 1991;10:209-215.
12. Hoover H. Compliance in hemodialysis patients: a review of the literature. J Am Diet Assoc. 1989;89:957-959.
13. Locatelli F. The need for better control of secondary hyperparathyroidism. Nephrol Dial Transplant. 2004;19(suppl 5):V15-V19.
14. Manley HJ, Garvin CG, Drayer DK, et al. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant. 2004;19:1842-1848.
15. Thomas LK, Sargent RG, Michels PC, Richter DL, Valois RF, Moore CG. Identification of the factors associated with compliance to therapeutic diets in older adults with end stage renal disease. J Ren Nutr. 2001;11:80-89.
16. Laidlaw JK, Beeken JE, Whitney FW, Reyes AA. Contracting with outpatient hemodialysis patients to improve adherence to treatment. ANNA J. 1999;26:37-40.
17. Gao C, Gruss E, Gonzalez S, Marco B, Fernandez J, Jarriz A. Compliance der Hämodialysepatienten zur verordneten Medikation [Compliance of haemodialysis patients with prescribed medications]. EDTNA ERCA J. 2000;26:4-6.
18. O'Brien ME. Compliance behavior and long-term maintenance dialysis. Am J Kidney Dis. 1990;15:209-214.
19. Safdar N, Baakza H, Kumar H, Naqvi SA. Non-compliance to diet and fluid restrictions in haemodialysis patients. J Pak Med Assoc. 1995;45:293-295.
20. Welch JL. Hemodialysis patient beliefs by stage of fluid adherence. Res Nurs Health. 2001;24:105-112.
21. Welch JL, Perkins SM, Evans JD, Bajpai S. Differences in perceptions by stage of fluid adherence. J Ren Nutr. 2003;13:275-281.
22. Zrinyi M. The influence of staff-patient interactions on adherence behaviours. EDTNA ERCA J. 2001;27:13-16.
23. Mai FM, Busby K, Bell RC. Clinical rating of compliance in chronic hemodialysis patients. Can J Psychiatry. 1999;44:478-482.
24. Rahman M, Fu P, Sehgal AR, Smith MC. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis. 2000;35:257-265.
25. Christensen AJ, Smith TW. Personality and patient adherence: correlates of the five-factor model in renal dialysis. J Behav Med. 1995;18:305-313.
26. Christensen AJ, Smith TW, Turner CW, Holman JM Jr, Gregory MC, Rich MA. Family support, physical impairment, and adherence in hemodialysis: an investigation of main and buffering effects. J Behav Med. 1992;15:313-325.
27. Szczech LA, Reddan DN, Klassen PS, et al. Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients. Nephrol Dial Transplant. 2003;18:1585-1591.
28. Morduchowicz G, Sulkes J, Aizic S, Gabbay U, Winkler J, Boner G. Compliance in hemodialysis patients: a multivariate regression analysis. Nephron. 1993;64:365-368.
29. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607-617.
30. Lopez-Gomez JM, Villaverde M, Jofre R, Rodriguez-Benitez P, Perez-Garcia R. Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int Suppl. January 2005:S63-S68.
31. Kimmel PL, Varela MP, Peterson RA, et al. Interdialytic weight gain and survival in hemodialysis patients: effects of duration of ESRD and diabetes mellitus. Kidney Int. 2000;57:1141-1151.
32. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15:458-482.
33. Schneider B. Multidimensional health locus of control as partial predictor of serum phosphorus in chronic hemodialysis. Psychol Rep. 1992;70:1171-1174.
34. Everett KD, Brantley PJ, Sletten C, Jones GN, McKnight GT. The relation of stress and depression to interdialytic weight gain in hemodialysis patients. Behav Med. 1995;21:25-30.
35. Casey J, Johnson V, McClelland P. The relationship between interdialytic weight gain and patient compliance: a single centred cohort study (n = 21). EDTNA ERCA J. 2001;27:187-189.
36. Christensen AJ, Moran PJ, Wiebe JS, Ehlers SL, Lawton WJ. Effect of a behavioral self-regulation intervention on patient adherence in hemodialysis. Health Psychol. 2002;21:393-397.
37. Takaki J, Nishi T, Shimoyama H, et al. Possible variances of blood urea nitrogen, serum potassium and phosphorus levels and interdialytic weight gain accounted for compliance of hemodialysis patients. J Psychosom Res. 2003;55:525-529.
38. Tsay SL. Self-efficacy training for patients with end-stage renal disease. J Adv Nurs. 2003;43:370-375.
39. Zrinyi M, Juhasz M, Balla J, et al. Dietary self-efficacy: determinant of compliance behaviours and biochemical outcomes in haemodialysis patients. Nephrol Dial Transplant. 2003;18:1869-1873.
40. Hitchcock PB, Brantley PJ, Jones GN, McKnight GT. Stress and social support as predictors of dietary compliance in hemodialysis patients. Behav Med. 1992;18:13-20.
41. Cleary DJ, Matzke GR, Alexander AC, Joy MS. Medication knowledge and compliance among patients receiving long-term dialysis. Am J Health Syst Pharm. 1995;52:1895-1900.
42. Sensky T, Leger C, Gilmour S. Psychosocial and cognitive factors associated with adherence to dietary and fluid restriction regimens by people on chronic haemodialysis. Psychother Psychosom. 1996;65:36-42.
43. Shaw-Stuart NJ, Stuart A. The effect of an educational patient compliance program on serum phosphate levels in patients receiving hemodialysis. J Ren Nutr. 2000;10:80-84.
44. Rocco MV, Burkart JM. Prevalence of missed treatments and early sign-offs in hemodialysis patients. J Am Soc Nephrol. 1993;4:1178-1183.
45. Brownbridge G, Fielding DM. Psychosocial adjustment and adherence to dialysis treatment regimes. Pediatr Nephrol. 1994;8:744-749.
46. Kimmel PL, Peterson RA, Weihs KL, et al. Behavioral compliance with dialysis prescription in hemodialysis patients. J Am Soc Nephrol. 1995;5:1826-1834.
47. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001;12:2131-2138.
48. Stamatakis M, Pecora P, Gunel E. Factors influencing adherence in chronic dialysis patients with hyperphosphatemia. J Ren Nutr. 1997;7:144-148.
49. Tanner JL, Craig CB, Bartolucci AA, et al. The effect of a self-monitoring tool on self-efficacy, health beliefs, and adherence in patients receiving hemodialysis. J Ren Nutr. 1998;8:203-211.
50. Hegel M, Teodoro A, Thiel G, Oulton B. Improving adherence to fluid restrictions in male hemodialysis patients: a comparison of cognitive and behavioral approaches. Health Psychol. 1992;11:324-330.
51. Bame SI, Petersen N, Wray NP. Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med. 1993;37:1035-1043.
52. Christensen AJ, Benotsch EG, Wiebe JS, Lawton WJ. Coping with treatment-related stress: effects on patient adherence in hemodialysis. J Consult Clin Psychol. 1995;63:454-459.
53. Lin CC, Liang CC. The relationship between health locus of control and compliance of hemodialysis patients. Kaohsiung J Med Sci. 1997;13:243-254.
54. Leggat JE Jr, Orzol SM, Hulbert-Shearon TE, et al. Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis. 1998;32:139-145.
55. Pang SK, Ip WY, Chang AM. Psychosocial correlates of fluid compliance among Chinese haemodialysis patients. J Adv Nurs. 2001;35:691-698.
56. Vlaminck H, Maes B, Jacobs A, Reyntjens S, Evers G. The dialysis diet and fluid non-adherence questionnaire: validity testing of a self-report instrument for clinical practice. J Clin Nurs. 2001;10:707-715.
57. Lee SH, Molassiotis A. Dietary and fluid compliance in Chinese hemodialysis patients. Int J Nurs Stud. 2002;39:695-704.
58. Durose CL, Holdsworth M, Watson V, Przygrodzka F. Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance. J Am Diet Assoc. 2004;104:35-41.
59. Hecking E, Bragg-Gresham JL, Rayner HC, et al. Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004;19:100-107.
60. Kugler C, Vlaminck H, Haverich A, Maes B. Nonadherence with diet and fluid restrictions among adults having hemodialysis. J Nurs Scholarsh. 2005;37:25-29.
61. Jaeger JQ, Mehta RL. Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol. 1999;10:392-403.
62. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
63. De Geest S, Abraham I, Dunbar-Jacob J. Measuring transplant patients' compliance with immunosuppressive therapy. West J Nurs Res. 1996;18:595-605.
64. Manley M, Sweeney J. Assessment of compliance in hemodialysis adaptation. J Psychosom Res. 1986;30:153-161.
65. Stragier A, Jadoul M. Daily weight gain and protein catabolic rate are lower over the long interdialytic interval. Clin Nephrol. 2003;60:22-27.
66. Sezer S, Ozdemir FN, Arat Z, Perim O, Turan M, Haberal M. The association of interdialytic weight gain with nutritional parameters and mortality risk in hemodialysis patients. Ren Fail. 2002;24:37-48.
67. Sherman RA, Cody RP, Rogers ME, Solanchick JC. Interdialytic weight gain and nutritional parameters in chronic hemodialysis patients. Am J Kidney Dis. 1995;25:579-583.
68. Testa A, Beaud JM. The other side of the coin: interdialytic weight gain as an index of good nutrition. Am J Kidney Dis. 1998;31:830-834.
69. Kaveh K, Kimmel PL. Compliance in hemodialysis patients: multidimensional measures in search of a gold standard. Am J Kidney Dis. 2001;37:244-266.
70. Kutner NG, Zhang R, McClellan WM, Cole SA. Psychosocial predictors of non-compliance in haemodialysis and peritoneal dialysis patients. Nephrol Dial Transplant. 2002;17:93-99.
71. Curtin RB, Svarstad BL, Keller TH. Hemodialysis patients' noncompliance with oral medications. ANNA J. 1999;26:307-316.
72. Keilani T, Schlueter W, Batlle D. Selected aspects of ACE inhibitor therapy for patients with renal disease: impact on proteinuria, lipids and potassium. J Clin Pharmacol. 1995;35:87-97.
73. De Geest S, Abraham I, Moons P, et al. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant. 1998;17:854-863.
74. Nevins TE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int. 2001;60:1565-1570.
75. Sherman RA, Cody RP, Matera JJ, Rogers ME, Solanchick JC. Deficiencies in delivered hemodialysis therapy due to missed and shortened treatments. Am J Kidney Dis. 1994;24:921-923.
76. Bleyer AJ, Hylander B, Sudo H, et al. An international study of patient compliance with hemodialysis. JAMA. 1999;281:1211-1213.
77. DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997;30:204-212.
78. Taskapan H, Ates F, Kaya B, et al. Psychiatric disorders and large interdialytic weight gain in patients on chronic haemodialysis. Nephrology (Carlton). 2005;10:15-20.
79. Saran R, Bragg-Gresham JL, Rayner HC, et al. Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003;64:254-262.
80. Goodman WG. Vascular calcification in end-stage renal disease. J Nephrol. 2002;15(suppl 6):S82-S85.
81. Port FK, Pisoni RL, Bragg-Gresham JL, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif. 2004;22:175-180.
82. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208-2218.
83. Kimmel PL, Peterson RA, Weihs KL, et al. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int. 1998;54:245-254.
84. Abdelfatah AB, Motte G, Ducloux D, Chalopin JM. Determinants of mean arterial pressure and pulse pressure in chronic haemodialysis patients. J Hum Hypertens. 2001;15:775-779.
85. Pastan S, Bailey J. Dialysis therapy. N Engl J Med. 1998;338:1428-1437.
86. Mallick NP, Hutchinson A, Patel M, Harty J. Factors influencing dialysis outcome: the dialysis dose in perspective. Nephrol Dial Transplant. 1998;13(suppl 6):152-157.
87. Wolfe RA, Hulbert-Shearon TE, Ashby VB, Mahadevan S, Port FK. Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002. Am J Kidney Dis. 2005;45:127-135.
88. Saran R, Canaud BJ, Depner TA, et al. Dose of dialysis: key lessons from major observational studies and clinical trials. Am J Kidney Dis. 2004;44:47-53.